These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 30052684)

  • 41. Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo.
    Westphal EM; Mauser A; Swenson J; Davis MG; Talarico CL; Kenney SC
    Cancer Res; 1999 Apr; 59(7):1485-91. PubMed ID: 10197618
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
    Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
    Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cells.
    Bristol JA; Brand J; Ohashi M; Eichelberg MR; Casco A; Nelson SE; Hayes M; Romero-Masters JC; Baiu DC; Gumperz JE; Johannsen EC; Dinh HQ; Kenney SC
    PLoS Pathog; 2022 Apr; 18(4):e1010453. PubMed ID: 35472072
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer.
    Zhao J; Jin H; Cheung KF; Tong JH; Zhang S; Go MY; Tian L; Kang W; Leung PP; Zeng Z; Li X; To KF; Sung JJ; Yu J
    Cancer; 2012 Feb; 118(4):924-36. PubMed ID: 21717425
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Natural Variations in BRLF1 Promoter Contribute to the Elevated Reactivation Level of Epstein-Barr Virus in Endemic Areas of Nasopharyngeal Carcinoma.
    Zhang JB; Huang SY; Wang TM; Dong SQ; He YQ; Zheng XH; Li XZ; Wang F; Jianbing M; Jia WH
    EBioMedicine; 2018 Nov; 37():101-109. PubMed ID: 30420297
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radiation-induced Epstein-Barr virus reactivation in gastric cancer cells with latent EBV infection.
    Nandakumar A; Uwatoko F; Yamamoto M; Tomita K; Majima HJ; Akiba S; Koriyama C
    Tumour Biol; 2017 Jul; 39(7):1010428317717718. PubMed ID: 28675108
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IRF4 promotes Epstein-Barr virus activation in Burkitt's lymphoma cells.
    Gao Y; Wang L; Lei Z; Li J; Forrest JC; Liang X
    J Gen Virol; 2019 May; 100(5):851-862. PubMed ID: 30907723
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An Epstein-Barr Virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model.
    Ma SD; Yu X; Mertz JE; Gumperz JE; Reinheim E; Zhou Y; Tang W; Burlingham WJ; Gulley ML; Kenney SC
    J Virol; 2012 Aug; 86(15):7976-87. PubMed ID: 22623780
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors.
    Countryman JK; Gradoville L; Miller G
    J Virol; 2008 May; 82(10):4706-19. PubMed ID: 18337569
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differentiation-Dependent KLF4 Expression Promotes Lytic Epstein-Barr Virus Infection in Epithelial Cells.
    Nawandar DM; Wang A; Makielski K; Lee D; Ma S; Barlow E; Reusch J; Jiang R; Wille CK; Greenspan D; Greenspan JS; Mertz JE; Hutt-Fletcher L; Johannsen EC; Lambert PF; Kenney SC
    PLoS Pathog; 2015 Oct; 11(10):e1005195. PubMed ID: 26431332
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epstein-Barr Virus Viral Processivity Factor EA-D Facilitates Virus Lytic Replication by Inducing Poly(ADP-Ribose) Polymerase 1 Degradation.
    Lee S; Kim J; Chung WC; Han JH; Song MJ
    J Virol; 2022 Nov; 96(21):e0037122. PubMed ID: 36286483
    [TBL] [Abstract][Full Text] [Related]  

  • 52. BZLF1 governs CpG-methylated chromatin of Epstein-Barr Virus reversing epigenetic repression.
    Woellmer A; Arteaga-Salas JM; Hammerschmidt W
    PLoS Pathog; 2012 Sep; 8(9):e1002902. PubMed ID: 22969425
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of a negative cis element within the ZII domain of the Epstein-Barr virus lytic switch BZLF1 gene promoter.
    Liu P; Liu S; Speck SH
    J Virol; 1998 Oct; 72(10):8230-9. PubMed ID: 9733866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Herpes simplex virus type 1 infection activates the Epstein-Barr virus replicative cycle via a CREB-dependent mechanism.
    Wu H; Li T; Zeng M; Peng T
    Cell Microbiol; 2012 Apr; 14(4):546-59. PubMed ID: 22188237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells.
    Van Sciver N; Ohashi M; Pauly NP; Bristol JA; Nelson SE; Johannsen EC; Kenney SC
    PLoS Pathog; 2021 Aug; 17(8):e1009783. PubMed ID: 34339458
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cellular transcription factor Oct-1 interacts with the Epstein-Barr virus BRLF1 protein to promote disruption of viral latency.
    Robinson AR; Kwek SS; Hagemeier SR; Wille CK; Kenney SC
    J Virol; 2011 Sep; 85(17):8940-53. PubMed ID: 21697476
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of Epstein-Barr virus reactivation in nasopharyngeal carcinoma cells by dietary sulforaphane.
    Wu CC; Chuang HY; Lin CY; Chen YJ; Tsai WH; Fang CY; Huang SY; Chuang FY; Lin SF; Chang Y; Chen JY
    Mol Carcinog; 2013 Dec; 52(12):946-58. PubMed ID: 22641235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus.
    Kraus RJ; Mirocha SJ; Stephany HM; Puchalski JR; Mertz JE
    J Virol; 2001 Jan; 75(2):867-77. PubMed ID: 11134300
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interplay between PKCδ and Sp1 on histone deacetylase inhibitor-mediated Epstein-Barr virus reactivation.
    Tsai PF; Lin SJ; Weng PL; Tsai SC; Lin JH; Chou YC; Tsai CH
    J Virol; 2011 Mar; 85(5):2373-85. PubMed ID: 21159880
    [TBL] [Abstract][Full Text] [Related]  

  • 60. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
    Ye J; Gradoville L; Daigle D; Miller G
    J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.